Top Markets
Coin of the day
BCAL Diagnostics Limited BCAL Diagnostics Limited

BCAL Diagnostics Limited

BDX
Rang in aandelen #31189
BCAL Diagnostics Limited is a biotechnology firm focused on creating an... BCAL Diagnostics Limited is a biotechnology firm focused on creating an advanced, non-surgical laboratory blood test for the identification of breast cancer. Its flagship product, the BCAL test, is a lipid biomarker-based blood assay designed for potential use in breast cancer prevention strategies, early screening, and ongoing patient monitoring. This in vitro diagnostic (IVD) technology functions by detecting a unique pattern of lipid biomarkers, which are isolated from extracellular vesicles present in a patient's plasma or blood, thereby enabling the diagnosis of breast cancer cells. Established in 2010, the company's main operations are based in Sydney, Australia.
Aandeelprijs
$0.03808538
Marktkapitalisatie
$14.04M
Verandering (1 dag)
-3.57%
Verandering (1 jaar)
6.63%
Land
AU
Handel BCAL Diagnostics Limited (BDX)

Categorie

Koersgeschiedenis voor BCAL Diagnostics Limited (BDX)
Hoogste slotkoers: $0.04 op 2026-08-01

Laagste slotkoers: $0.15 op 2021-07-01
Koersgeschiedenis van BCAL Diagnostics Limited van 2021 tot 2026
Jaarlijkse koersprestatie
Jaar Prestaties
2026 (TTM) -14.06%
2025 6.49%
2024 -5.30%
2023 59.08%
2022 -54.80%
2021 0.00%
Aandelenkoers van vergelijkbare bedrijven of concurrenten
Bedrijf Aandelenkoers Verandering 1jr% Land
$591.22 21.26%
US
$200.34 -4.15%
US
$24.23 79.49%
CN
$312.51 93.92%
US
$557.21 -12.64%
US